Zynex Total Assets 2006-2019 | ZYXI

Zynex total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zynex Annual Total Assets
(Millions of US $)
2018 $16
2017 $9
2016 $4
2015 $4
2014 $7
2013 $17
2012 $26
2011 $22
2010 $16
2009 $12
2008 $11
2007 $7
2006 $3
2005 $1
Zynex Quarterly Total Assets
(Millions of US $)
Q2 2019 $22
Q1 2019 $19
Q4 2018 $19
Q3 2018 $13
Q2 2018 $11
Q1 2018 $9
Q4 2017 $9
Q3 2017 $6
Q2 2017 $4
Q1 2017 $4
Q4 2016 $4
Q3 2016 $5
Q2 2016 $4
Q1 2016 $4
Q4 2015 $4
Q3 2015 $5
Q2 2015 $5
Q1 2015 $6
Q4 2014 $7
Q3 2014 $10
Q2 2014 $11
Q1 2014 $16
Q4 2013 $17
Q3 2013 $23
Q2 2013 $24
Q1 2013 $25
Q4 2012 $26
Q3 2012 $26
Q2 2012 $25
Q1 2012 $24
Q4 2011 $22
Q3 2011 $21
Q2 2011 $19
Q1 2011 $17
Q4 2010 $16
Q3 2010 $15
Q2 2010 $13
Q1 2010 $14
Q4 2009 $12
Q3 2009 $12
Q2 2009 $12
Q1 2009 $12
Q4 2008 $11
Q3 2008 $14
Q2 2008 $11
Q1 2008 $9
Q4 2007 $7
Q3 2007 $5
Q2 2007 $4
Q1 2007 $3
Q4 2006 $3
Q3 2006 $2
Q2 2006 $2
Q1 2006 $2
Q4 2005 $1
Q3 2005 $1
Q2 2005 $1
Q1 2005 $1
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.384B $0.032B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.155B 20.38
Abbott Laboratories (ABT) United States $144.891B 27.24
Stryker (SYK) United States $80.414B 27.81
Boston Scientific (BSX) United States $53.574B 25.99
Baxter (BAX) United States $44.796B 27.16
EssilorLuxottica Societe Anonyme (ESLOY) France $32.784B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.311B 18.12
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.166B 0.00
Terumo (TRUMY) Japan $23.897B 29.82
Smith & Nephew SNATS (SNN) United Kingdom $20.556B 0.00
ResMed (RMD) United States $18.755B 35.74
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.968B 53.44
Insulet (PODD) United States $9.367B 555.07
Perrigo (PRGO) Ireland $7.321B 13.49
Canopy Growth (CGC) Canada $6.992B 0.00
Hill-Rom Holdings (HRC) United States $6.758B 20.15
Haemonetics (HAE) United States $6.423B 48.47
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.717B 0.00
Neogen (NEOG) United States $3.401B 56.90
NuVasive (NUVA) United States $3.312B 26.40
ICU Medical (ICUI) United States $3.149B 20.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.522B 0.00
Quidel (QDEL) United States $2.431B 24.14
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
National Vision Holdings (EYE) United States $1.919B 41.42
Cardiovascular Systems (CSII) United States $1.617B 0.00
Aphria (APHA) $1.368B 0.00
VAREX IMAGING (VREX) United States $1.117B 25.74
AtriCure (ATRC) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.885B 14.39
Eagle Pharmaceuticals (EGRX) United States $0.847B 21.60
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.778B 18.37
Omeros (OMER) United States $0.764B 0.00
Lantheus Holdings (LNTH) United States $0.742B 19.50
LeMaitre Vascular (LMAT) United States $0.670B 39.72
Cerus (CERS) United States $0.633B 0.00
Surmodics (SRDX) United States $0.607B 115.31
MacroGenics (MGNX) United States $0.562B 0.00
Quanterix (QTRX) United States $0.554B 0.00
OraSure Technologies (OSUR) United States $0.510B 23.60
TG Therapeutics (TGTX) United States $0.507B 0.00
Meridian Bioscience (VIVO) United States $0.423B 13.21
Owens & Minor (OMI) United States $0.406B 12.17
Utah Medical Products (UTMD) United States $0.342B 25.05
BioLife Solutions (BLFS) United States $0.329B 101.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.321B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.179B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.148B 0.00
Female Health (VERU) United States $0.137B 0.00
Fonar (FONR) United States $0.131B 9.16
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
Chimerix (CMRX) United States $0.088B 0.00
United-Guardian (UG) United States $0.086B 20.46
Nephros (NEPH) United States $0.077B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00